URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS
The present invention provides compounds of Formula I or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors .
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English Slovenian |
Published |
26.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides compounds of Formula I
or pharmaceutically acceptable salt forms thereof, wherein R a , R b , R c , R d , D, W, R 1a , R 1b , R 1c , Y, R 3 , X, E and G are as defined herein, and uses as AXL and c-MET kinase inhibitors . |
---|---|
Bibliography: | Application Number: SI20120030843 |